Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05250349 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure

Study acronym: TRACE-IMPAIR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 22, 2022 (before its estimated September 1, 2022 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
TRACE-IMPAIR is a prospective, clinical study of consecutive patients that evaluates the relationship between heart failure (HF) and cognitive impairment in relation to carotid and cerebral flow. The carotid and cerebral flow will be assessed using Doppler ultrasonography, and cognitive function will be estimated during routine neuropsychological tests. It is an observational, three(natural)-group, single-center study. It is also an Academic Registry - the scientific activity of the Faculty of Medicine, Collegium Medicum, Jagiellonian University, and John Paul II Hospital.
Trial Details
NCT Number NCT05250349
Lead Sponsor John Paul II Hospital, Krakow
Conditions
(from sponsor)		 Heart Failure, Cognitive Impairment, Carotid Stenosis
Related terms Carotid Stenosis, Cognitive Dysfunction, Heart Failure
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov